Meeting Swiss Federal Food Safety and Veterinary Office (FSVO) Standards for NHP Housing

PROVEN INTELLIGENCE ACCELERATING NEXT-GENERATION THERAPIES

Meeting Swiss Federal Food Safety and Veterinary Office (FSVO) Standards for NHP Housing

FSVO-Compliant NHP Housing for Advanced Therapy Programs

CELL & GENE | RNA | BIOLOGICS

Meeting the stringent non-human primate (NHP) housing and welfare standards set by the Swiss Federal Food Safety and Veterinary Office (FSVO) is a prerequisite for conducting studies intended for Swiss regulatory submission. These standards, which emphasize complex social housing, extensive environmental enrichment, and positive reinforcement training, directly impact the quality and reproducibility of preclinical data. Franklin Biolabs provides GxP-compliant NHP programs that are designed to meet or exceed FSVO requirements, ensuring data integrity for advanced therapy IND filings and supporting global regulatory acceptance.

A marketing fact sheet from Franklin Biolabs about the scientific benefits of Mauritian cynomolgus macaques for preclinical research, featuring a photo of the primates.

A stylized rendering of a DNA double helix on the left side of a light blue gradient background.

Frequently Asked Questions: Swiss FSVO NHP Standards

Question Franklin Biolabs’ Approach
What are the key differences between Swiss FSVO and EU Directive 2010/63/EU for NHP housing? The FSVO mandates more specific and often more rigorous standards for social housing configurations, minimum enclosure volumes, and the complexity of structural environmental enrichment compared to the baseline requirements of the EU Directive. Our protocols are designed to the highest applicable standard.
How does environmental enrichment impact GxP study data variability? A properly enriched environment reduces stress-related physiological responses and abnormal behaviors. This creates a more stable biological baseline, minimizing non-test-article-related variability in study endpoints and leading to more reliable and reproducible data.
What are the specific cage dimension and social housing requirements under FSVO? FSVO regulations detail specific volumetric and height requirements based on species and body weight, and they strongly mandate pair or group housing unless scientifically or medically contraindicated. We implement and document detailed social compatibility assessments to establish stable NHP groups.
How are health monitoring and veterinary care protocols documented for FSVO compliance? All veterinary interventions, daily health observations, and enrichment activities are recorded in GxP-compliant electronic systems. This provides a complete, auditable trail demonstrating proactive animal welfare management that aligns with FSVO expectations for comprehensive oversight.

Aligning In Vivo Operations with Swiss Regulatory Expectations

For sponsors targeting Swissmedic approval, adherence to the FSVO’s animal welfare ordinance is not optional. These regulations are among the most detailed globally, focusing on species-specific needs to ensure the psychological well-being of NHPs. This regulatory framework recognizes that physiological stability, achieved through superior husbandry, is the foundation of scientifically valid research. Franklin Biolabs’ vivarium operations are architected to satisfy these precise requirements, facilitating study execution for programs with a global regulatory strategy that includes Switzerland.

<p style=”text-align: center; font-size: 0.

A close-up, blue-toned image of scientific glassware, featuring vials placed in a dish filled with clear, spherical beads, suggesting a laboratory or research setting.

A scientist in a modern lab analyzes colorful DNA sequencing data on a tablet.

The Impact of Advanced Husbandry on Data Integrity

High-quality preclinical data depends on minimizing confounding variables. An animal’s environment is a primary source of such variables. By implementing FSVO-aligned enrichment and social housing strategies, we reduce chronic stress and promote species-typical behaviors. This environmental control is foundational for accurately assessing the safety and efficacy of novel therapeutics.

For instance, evaluating the safety profile of an AAV-based gene therapy requires a stable biological system to detect subtle test-article-related effects (PMID: 35333110). A low-stress NHP model, housed in a compliant and enriching environment, provides the clean background necessary to generate the unambiguous safety data required by regulators.

GxP Infrastructure and Animal Welfare

  • Accreditation: We maintain full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and are registered with the U.S. Department of Agriculture (USDA).

  • The 3Rs: Our scientific staff and veterinarians actively apply the principles of Replacement, Reduction, and Refinement to all study designs, a core tenet of both U.S. and Swiss federal law.

  • Facility: Our >100,000 sq ft GxP-compliant facility includes dedicated, configurable NHP housing suites that can be adapted to meet specific social and enrichment protocols demanded by agencies like the FSVO.

This infrastructure, combined with our scientific expertise, supports an average 18-24 month timeline to IND. The core scientific team responsible for these services has achieved a 100% IND success rate since 2019, continuing this legacy of quality with the launch of the Franklin Biolabs brand in 2024.

Scientific Process Diagram

This content is for informational purposes. For guidance specific to your therapeutic program, please contact our team for a consultation.

Explore More Capabilities